Plantar Fasciitis Treatment Market by Type and Forecast to 2027

Š2019 Transparency Market Research, All Rights Reserved

Plantar Fasciitis Treatment Market Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others; End User: Hospitals, Clinics, and Others Forecast From 2019 - 2027

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Table of Content Sr. No.

Content

Chapter1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Executive Summary: Global Plantar Fasciitis Treatment Market

Chapter 4

Market Overview

Chapter 5

Market Outlook

Chapter 6

Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

Chapter 7

Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End User

Chapter 8

Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

Chapter 9

North America Plantar Fasciitis Treatment Market Analysis and Forecast

Chapter 10

Europe Plantar Fasciitis Treatment Market Analysis and Forecast

Chapter 11

Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

Chapter 12

Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

Chapter 13

Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

Chapter 14

Competition Landscape

©2019 Transparency Market Research, All Rights Reserved

Plantar Fasciitis Treatment Market: Snapshot •

Plantar fasciitis is one of the most common foot pain conditions. Plantar fasciitis is primarily caused due to repetitive strain on the ankle, leading to progressive wear and tear and degeneration of plantar fascia, a thick connective tissue covering the lower side of the foot.

•

The multi-factorial etiology of plantar fasciitis has led to a significant surge in the number of sufferers, while laying a firm base for the growth of companies that provide treatment for this condition.

•

Key Players - Hanger, Inc., Bayer Group (Dr. Scholl's), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.

©2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

Š2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved

Reports Highlights • The global plantar fasciitis treatment market was valued at ~ US$ 695 Mn in 2018, and is projected to expand at a CAGR of 4.3% from 2019 to 2027. .

• Rise in the number of individuals living sedentary lifestyles coupled with changes in eating habits leads to an increase in obesity, which puts pressure on the joints and ankles, and can result in plantar fasciitis.

• Increase in the percentage of geriatric and obese populations is likely to propel the number of patients suffering from plantar fasciitis.

• Increase in the number of patients suffering from plantar fasciitis, and rise in the number of patients coming in through reimbursement programs such as Medicare.

©2019 Transparency Market Research, All Rights Reserved

Request Sample

Š2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com For sales queries or new topics email us on:

sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030

T

H

A Y

N O

K U